- mitomycin
- Antibiotic produced by Streptomyces caespitosus, variants of which are designated m. A, m. B, etc.; m. C is an antineoplastic agent and a bacteriocide; inhibits DNA synthesis.
* * *
mi·to·my·cin .mīt-ə-'mīs-ən n1) a complex of antibiotic substances which is produced by a Japanese bacterium of the genus Streptomyces (S. caespitosus)2) a component C15H18N4O5 of mitomycin that inhibits DNA synthesis and is used as an antineoplastic in the palliative treatment of some carcinomas called also mitomycin C* * *
an anthracycline antibiotic that inhibits the growth of cancer cells. It causes severe marrow suppression but is of use in the treatment of stomach and breast cancers. Trade name: Mitomycin C Kyowa.* * *
mi·to·my·cin (mi″to-miґsin) any of a group of antitumor antibiotics (e.g., mitomycin A, B, C) produced by Streptomyces caespitosus. [USP] mitomycin C, which acts as a bifunctional or trifunctional alkylating agent causing cross-linking of DNA and inhibition of DNA synthesis and is relatively phase-specific for the late G1 and early S phases of the cell cycle. It has activity against many types of carcinoma as well as chronic myelogenous leukemia, but because of its severe toxicity and myelosuppression it is usually used only for palliation in patients who have not responded to other treatment. Administered intravenously.
Medical dictionary. 2011.